🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
2,648.00
+27.00 (1.03%)
At close: Nov 20, 2026

Glenmark Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
747,331601,567434,866270,463131,124124,718
Market Cap Growth
43.86%38.33%60.79%106.27%5.14%-4.88%
Enterprise Value
748,495586,905434,470315,126164,781152,778
Last Close Price
2648.002131.181534.75952.84461.39435.94

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
51.5144.1741.53-44.1113.24
PS Ratio
4.673.533.252.141.131.01
PB Ratio
6.675.724.913.451.331.32
P/TBV Ratio
8.647.515.894.151.861.83
P/FCF Ratio
-28.82--743.8039.15
P/OCF Ratio
184.0117.46--20.9711.25

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
4.683.443.252.491.411.24
EV/EBITDA Ratio
22.4913.1019.1917.2211.537.99
EV/EBIT Ratio
27.6714.4622.7821.8014.488.30
EV/FCF Ratio
-28.12--934.7147.96

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.130.060.280.160.470.42
Debt / EBITDA Ratio
0.420.131.050.643.031.98
Debt / FCF Ratio
-0.28--261.3812.44
Net Debt / Equity Ratio
0.01-0.060.09-0.050.350.27
Net Debt / EBITDA Ratio
0.04-0.130.35-0.242.411.33
Net Debt / FCF Ratio
-0.14-0.28-0.500.37195.117.99
Asset Turnover
0.790.950.880.750.640.75
Inventory Turnover
1.481.531.631.871.811.90
Quick Ratio
0.901.110.940.751.061.08
Current Ratio
1.691.771.561.282.101.77
Return on Equity (ROE)
13.96%14.07%12.54%-20.70%-0.93%12.04%
Return on Assets (ROA)
7.18%7.58%6.89%-8.90%1.63%5.76%
Return on Invested Capital (ROIC)
21.21%28.48%16.74%-700.97%-3.36%11.09%
Return on Capital Employed (ROCE)
19.50%30.00%18.90%16.90%8.00%14.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
1.94%2.26%2.41%-5.55%2.27%7.55%
FCF Yield
-1.11%3.47%-3.63%-4.30%0.13%2.55%
Dividend Yield
0.09%0.24%0.16%0.26%0.54%0.57%
Payout Ratio
14.63%10.36%6.73%-23.68%9.84%
Buyback Yield / Dilution
-0.01%-0.03%-0.01%-0.00%--
Total Shareholder Return
0.09%0.21%0.15%0.26%0.54%0.57%